Dr. John G. Devlin
Claim this profileRiddle Memorial Hospital
Studies Cancer
Studies Non-Small Cell Lung Cancer
4 reported clinical trials
10 drugs studied
Area of expertise
1Cancer
Stage IV
Stage II
Stage III
2Non-Small Cell Lung Cancer
Stage II
Stage III
Stage I
Affiliated Hospitals
Clinical Trials John G. Devlin is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
More about John G. Devlin
Clinical Trial Related9 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments John G. Devlin has experience with
- Pembrolizumab
- Pemetrexed Disodium
- Carboplatin
- Gemcitabine Hydrochloride
- Paclitaxel
- Biospecimen Collection
Breakdown of trials John G. Devlin has run
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Squamous Cell Carcinoma
Renal Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John G. Devlin specialize in?
John G. Devlin focuses on Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage II.
Is John G. Devlin currently recruiting for clinical trials?
Yes, John G. Devlin is currently recruiting for 3 clinical trials in Media Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that John G. Devlin has studied deeply?
Yes, John G. Devlin has studied treatments such as Pembrolizumab, Pemetrexed Disodium, Carboplatin.
What is the best way to schedule an appointment with John G. Devlin?
Apply for one of the trials that John G. Devlin is conducting.
What is the office address of John G. Devlin?
The office of John G. Devlin is located at: Riddle Memorial Hospital, Media, Pennsylvania 19063 United States. This is the address for their practice at the Riddle Memorial Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.